[1]
Soler, E.P.; Casado Ruiz, V. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: Similarities and differences. Curr. Cardiol. Rev., 2010, 6(3), 138-149.
[2]
Brouns, R.; De Deyn, P. The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg., 2009, 111(6), 483-495.
[3]
Hong, J.T.; Ryu, S.R.; Kim, H.J.; Lee, J.K.; Lee, S.H.; Yun, Y.P.; Lee, B.M.; Kim, P.Y. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res., 2001, 888(1), 11-18.
[4]
Hou, R-R.; Chen, J-Z.; Chen, H.; Kang, X-G.; Li, M-G.; Wang, B-R. Neuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell Boil. Int., 2008, 32(1), 22-30.
[5]
Sutherland, B.A.; Shaw, O.M.; Clarkson, A.N.; Jackson, D.N.; Sammut, I.A.; Appleton, I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: Novel mechanisms of action. FASEB J., 2005, 19(2), 258-260.
[6]
Zhang, F.; Li, N.; Jiang, L.; Chen, L.; Huang, M. Neuroprotective effects of (−)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation. Neurochem. Res., 2015, 40(8), 1691-1698.
[7]
Mukherjee, S.; Ray, S.; Thakur, R. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J. Pharm. Sci., 2009, 71(4), 349-358.
[8]
Üner, M.; Yener, G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine, 2007, 2(3), 289-300.
[9]
Wissing, S.; Kayser, O.; Müller, R. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev., 2004, 56(9), 1257-1272.
[10]
Müller, R.H.; Radtke, M.; Wissing, S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 2002, 54, S131-S155.
[11]
Garud, A.; Singh, D.; Garud, N. Solid lipid nanoparticles (SLN): Method, characterization and applications. Int. Curr. Pharm. J., 2012, 1(11), 384-393.
[12]
Kushwaha, A.K.; Vuddanda, P.R.; Karunanidhi, P.; Singh, S.K.; Singh, S. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res. Int., 2013, 2013, 584589.
[13]
Kumar, R.; Sinha, V. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf. B Biointerfaces, 2014, 117, 82-88.
[14]
Manjunath, K.; Reddy, J.S.; Venkateswarlu, V. Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol., 2005, 27(2), 127-144.
[15]
Park, J-W.; Hong, J-S.; Lee, K-S.; Kim, H-Y.; Lee, J-J.; Lee, S-R. Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia. J. Nutr. Biochem., 2010, 21(11), 1038-1044.
[16]
Lim, S.H.; Kim, H.S.; Kim, Y.K.; Kim, T-M. Im, S.; Chung, M.E.; Hong, B.Y.; Ko, Y.J.; Kim, H.W.; Lee, J.I. The functional effect of epigallocatechin gallate on ischemic stroke in rats. Acta Neurobiol. Exp. (Wars.), 2010, 70(1), 40-46.
[17]
Medhi, B.; Prakash, A. Practical manual of experimental and clinical pharmacology. Jaypee Brothers, Medical Publishers Pvt. Limited:; , 2010.
[18]
Narkhede, K.P.; Kulkarni, A.R.; Savant, C. Attenuation of neuronal damage by gymnemic acid in experimentally induced cerebral ischemia in rats. J. App. Pharm. Sci., 2016, 6(6), 113-118.
[19]
Ansari, M.; Hussain, S.; Mudagal, M.; Goli, D. Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats. Eur. Rev. Med. Pharmacol. Sci., 2013, 17(2), 170-178.
[20]
Kumar, B.; Kuhad, A.; Chopra, K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: Behavioral and biochemical evidences. Psychopharmacology., 2011, 214(4), 819-828.
[21]
Chamorro, Á.; Dirnagl, U.; Urra, X.; Planas, A.M. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol., 2016, 15(8), 869-881.
[22]
Nidhin, M.; Indumathy, R.; Sreeram, K.; Nair, B.U. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull. Mater. Sci., 2008, 31(1), 93-96.
[23]
De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine, 2008, 3(2), 133-149.
[24]
Liu, J.; Hu, W.; Chen, H.; Ni, Q.; Xu, H.; Yang, X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 2007, 328(2), 191-195.
[25]
Helgason, T.; Awad, T.; Kristbergsson, K.; McClements, D.J.; Weiss, J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J. Colloid Interface Sci., 2009, 334(1), 75-81.
[26]
Freitas, C.; Müller, R.H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int. J. Pharm., 1998, 168(2), 221-229.
[27]
Nazemiyeh, E.; Eskandani, M.; Sheikhloie, H.; Nazemiyeh, H. Formulation and physicochemical characterization of lycopene-loaded solid lipid nanoparticles. Adv. Pharm. Bull., 2016, 6(2), 235-241.
[28]
Shi, F.; Wei, Z.; Zhao, Y.; Xu, X. Nanostructured lipid carriers loaded with baicalin: an efficient carrier for enhanced antidiabetic effects. Pharmacogn. Mag., 2016, 12(47), 198-202.
[29]
Gokce, E.H.; Korkmaz, E.; Dellera, E.; Sandri, G.; Bonferoni, M.C.; Ozer, O. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: Evaluation of antioxidant potential for dermal applications. Int. J. Nanomedicine, 2012, 7, 1841-1850.
[30]
Das, S.; Ng, W.K.; Kanaujia, P.; Kim, S.; Tan, R.B. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables. Colloids Surf. B Biointerfaces, 2011, 88(1), 483-489.
[31]
Haque, A.M.; Hashimoto, M.; Katakura, M.; Hara, Y.; Shido, O. Green tea catechins prevent cognitive deficits caused by Aβ 1-40 in rats. J. Nutr. Biochem., 2008, 19(9), 619-626.
[32]
Medhi, B.; Aggarwal, R.; Chakrabarti, A. Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice. Indian J. Exp. Biol., 2010, 48(8), 793-799.
37
4
1
1